Abstract
1 Sotalol 400 mg orally was given to five healthy male volunteers as a single dose and then subsequently once daily for 8 days.
2 Following the single dose and again after the eighth daily dose, blood samples were obtained at 3, 7, 12, 24, 36 and 48 h for plasma sotalol estimation.
3 During the 8-day course of sotalol 400 mg once daily, the effect was assessed by exercise testing and blood samples drawn for plasma sotalol measurement at 0 and 3 h with each dose.
4 The elimination half-life after chronic administration (17.7 ± 2.6 h) was not significantly different from that obtained after the single dose (15.5 ± 1.2 h). No difference occurred either in the comparable plasma concentrations on both elimination curves. It would appear, therefore, that chronic administration of sotalol does not alter its kinetics.
5 Drug accumulation, measured as AUCss / AUC1, showed a mean value of 0.95 ± 0.18, indicating that accumulation had not occurred.
6 Mean reduction of exercise heart rate ranged from a minimum of 20.5 ± 2.0% at time 0 on Day 8 to a maximum of 38.7 ± 1.1% at +3 h on Day 4. The minimum blockade in any individual during the 8 days was 14.5%.
7 There was a significant correlation between percentage reduction in exercise heart rate and plasma sotalol concentration.
8 Once daily administration of sotalol 400 mg orally would, therefore, appear to be an effective therapeutic regimen when sustained β-adrenoceptor blockade is required.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Brown H. C., Carruthers S. G., Kelly J. G., McDevitt D. G., Shanks R. G. Observations on the efficacy and pharmacokinetics of sotalol after oral administration. Eur J Clin Pharmacol. 1976 Mar 22;09(5-6):367–372. doi: 10.1007/BF00606550. [DOI] [PubMed] [Google Scholar]
- Taylor S. H., Meeran M. K. Different effects of adrenergic beta-receptor blockade on heart rate response to mental stress, catecholamines, and exercise. Br Med J. 1973 Nov 3;4(5887):257–259. doi: 10.1136/bmj.4.5887.257. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tjandramaga T. B., Verbeeck R., Thomas J., Verbesselt R., Verberckmoes R., Schepper P. J. The effect of end-stage renal failure and haemodialysis on the elimination kinetics of sotalol. Br J Clin Pharmacol. 1976 Apr;3(2):259–265. doi: 10.1111/j.1365-2125.1976.tb00601.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wagner J. G., Northam J. I., Alway C. D., Carpenter O. S. Blood levels of drug at the equilibrium state after multiple dosing. Nature. 1965 Sep 18;207(5003):1301–1302. doi: 10.1038/2071301a0. [DOI] [PubMed] [Google Scholar]